ࡱ> #` bjbjmm ^    """8Z$~ 'c(bbbbbbb9ehghb "b b;;;  b;b;;Y J_ pK) "[>bb0'c[V h h|J_J_ h _;bbR'c D" "  FOR IMMEDIATE RELEASE Contact: Catie Coman National Psoriasis Foundation 800.723.9166 x367 971.570.5884 (cell) HYPERLINK "mailto:ccoman@psoriasis.org"ccoman@psoriasis.org National Psoriasis Foundation launches Medical Dermatology Fellowship Program Twelve residents awarded fellowships to study medical dermatology PORTLAND, Ore. (June 30, 2010)Twelve dermatology residents from leading medical schools around the country each received a $40,000, one-year fellowship grant to study medical dermatology. The fellowships, awarded by the National Psoriasis Foundation (NPF), provide support to eligible institutions to develop and enhance opportunities for physicians training for careers in medical dermatology. The 12 medical dermatology fellows who will study psoriasis and other skin diseases are: Tina Bhutani, M.D., of the University of California, San Francisco., will focus on testing new therapeutic agents in psoriasis clinical trials. Amylynne Frankel, M.D., of Mt. Sinai School of Medicine in New York City, will study retinoid-related side effects in psoriasis patients treated with both acitretin and phototherapy. Stephanie A. Hirano, M.D., of Eastern Virginia Medical School in Norfolk, Va., will test new treatments for psoriasis, atopic dermatitis, sarcoidosis and acne in clinical trials. Sinead M. Langan, MSc, Ph.D., of the University of Pennsylvania in Philadelphia, will determine the impact of psoriasis on cardiovascular risk as well as the methodologies for comparative effectiveness research in psoriasis. Johnathan Ledet, M.D., of the University of Alabama in Birmingham, will study disorders of ethnic skin and hair. Robert Lott, M.D., of Wake Forest University in Winston-Salem, N.C., will examine new strategies to encourage better adherence to psoriasis treatments. Julia Minocha, M.D., of The Feinberg School of Medicine at Northwestern University in Evanston, Ill., will work to develop an information system to measure patient-reported outcomes. Amanda Robinson, M.D., of the Massachusetts General Hospital and Harvard University Medical School in Boston, will design and validate a physician global assessment instrument for psoriasis clinical trials. Aieska de Souza, M.D., of the New York University School of Medicine in New York City, will investigate the microbiome, or genetic elements, of psoriasis and healthy skin. Marie Tuttle, M.D., of Case Western Reserve University and the University Hospitals of Cleveland in Cleveland, Ohio, will examine the physiology of biofilms, a moist coating derived from bacteria and fungi that can interfere with wound healing. (more) Andrew Wang, M.D., of Tufts University School of Medicine in Boston, will measure the incidence of metabolic syndrome in children with moderate to severe psoriasis. Jamie Woodcock, M.D., of the University of Utah School of Medicine in Salt Lake City, will explore the ability of anti-TNF agents to alter cardiovascular risk in psoriasis. These individuals are the next generation of talented, research-focused dermatologists, and the National Psoriasis Foundation is honored to support their careers with these fellowships, said Lawrence Green, M.D., of the National Psoriasis Foundation Board of Trustees. The Psoriasis Foundation is committed to advancing the science and practice of dermatology by providing educational support for these physicians of the future. The fellows were nominated by department chairs and fellowship/residency program directors at their respective universities and hospitals, and were selected by a committee comprised of leaders in dermatology. Since 1975, the NPF has awarded more than $6 million in grants to support promising psoriasis research. In 2009-2010, the Psoriasis Foundation awarded more than $1.2 million in research grants, the largest yearly amount ever awarded by the Foundation. To learn more about the Psoriasis Foundations grant program, visit www.psoriasis.org/research/grants. ### About Psoriasis Psoriasis is the most prevalent autoimmune disease in the country, affecting as many as 7.5 million Americans. Appearing on the skin most often as red scaly patches that itch and bleed, psoriasis is chronic, painful, disfiguring and disabling. Up to 30 percent of people with psoriasis develop psoriatic arthritis, a related joint disease. There is no cure for psoriasis. About the National Psoriasis Foundation The National Psoriasis Foundation is the world's largest nonprofit organization serving people with psoriasis and psoriatic arthritis. Our mission is to find a cure for psoriasis and psoriatic arthritis and to eliminate their devastating effects through research, advocacy and education. For more information, call the Psoriasis Foundation, headquartered in Portland, Ore., at 800.723.9166, or visit HYPERLINK "http://www.psoriasis.org/"www.psoriasis.org.      \]rs  ' ( F G T e / @ C i ߻߱߻ߕzobzSzh ~hJCJOJQJaJhJ5CJOJQJaJhc.EhJOJQJhJCJOJQJaJh<hJCJOJQJaJh<hJ5CJOJQJaJ hJ5 hJ56h+3xhJ56h+3xhJ5h0hJ0JjhlbUjhJUhJ h0hJh0hJ5jhJUmHnHu ^rF G . / x , LB & Fgd  & FgdS] & FgdBa & Fgdc.Egd+3x$a$gd+3xgdXx i w x + , J  $~,*JKLABCȸȸȸȸȱȥȆȆvaP h,&<hJ5B*OJQJph(h,&<hJ5B*CJOJQJaJphh hJ5CJOJQJaJh#CDhJCJOJQJaJh<hJ5CJOJQJaJh hJ5OJQJ hS]hJhc.EhJ5CJOJQJaJhJCJOJQJaJhJ5CJOJQJaJhBahJ5CJOJQJaJhBahJCJOJQJaJBCJOP"# !   gdc 7$8$H$^gdWgdc 7$8$H$gdP$a$gdcgdHogd# & Fgdc.E $8^8a$gd)+8^8gd)+CIJ]WXY=a]^͵vffvf^S^jhlbUjhJUh0hJ5CJOJQJaJh0hJCJOJQJaJh0hJ^JhPhJ5 h0hJh0hJ5 hJ5 h hJhJh#hJ5OJQJhEhJ5OJQJhJCJOJQJaJhJ5CJOJQJaJhVzChJOJQJhVzChJCJOJQJaJ    hlbjhlbU h0hJh0hJ5CJOJQJaJjhJU#h0hJ0J5CJOJQJaJ  7$8$H$^gdWgdc:&P1hP:pF/ =!"#$% n o,AB/T+߂tPNG  IHDRvc]sRGBgAMA a cHRMz&u0`:pQ< pHYs!!rIDATx^ vSͥJc*Bɜs(B*s 2(LH2Sd()C=&Mwuksq}kZt͒,.eڴi_WN n vjuF?>Al 7_6s̎"|ܞN0n3je]cc@rIM))Ұ*R CE c"9ζngBT[,kaUaW_($CqR3p'32z/K0zsc/H1bu˵ՏMCc:տ9昣cg O7L1eJPosg&D{fm9X5,}ON $py)+ԅO?li{D闤& d%g;o'INOJѐc2m#CC\s.τP$e&dL^aL&EYgeykD0&ݧa$pz$};щe#`#*E, YS 8(Kh=#!EXc5N]EIPDOK/>O/UJE'pI Yobʔ)٣>5J[oE#*IT'MCCC3EL$ +awb.F}SjIr!ݓa&T_W]Zy /wbgϖZjgR/L7-8 ;&@A`8#Ty)Tjgț(aDk_ w"doX}]V2^}/:(g\`~zD] PM\Zk vۭv؋.Icy 3 u Dv{{z*7ȁ?w-iJT}wznH0X~;ŏ01U矯 +y /?-xzHw{=/R^NOr*֕i8_T |ʬ~%tD0=^ߍpij@"qUyt_yqjdH0Pǽ\;$@AG\Bյ <PҊgsҳg$nAQ à(^s-oyK8wqtpu ^ } $+~mH0@ǼFDdyH ZjBr "$%_?1:`CtO(?t E h :;z]w&}K{v:K/ .U&Rz $p@VA 0=uQst;ހot#k')# Fe% N(=8T ^0z1hQ,Z+ px_}{CwȡDz;Gob}0M鑚HPz /bG:Π"{s0stHڷI&z ZR Ck`?=c..mgM7ug9ٔ]sRhxӛ#Wf! _n=8?O:5ȧ~UGzHP0=чSXr%Ek+ر#EE @V|o䀔ϖ2cƌo{X鄶cv-+9UHCHAHB >1EYW E6 -TJyml(iI+_l@HD0ހoIP0H_bq{IJOlnwŀSH3$_Wb-A|3qR@dR[P C83COevsQ/dq}8DunzGy)dpꩧ =/%'`s\O$94l%Cua0|c܌Z7G얓y?G\C{6.qփڜrP mjNLmfYH. ecg=D2PS}@+5rѷi~o|ږ#pMq-uGw>M"2pE-\[!=D[lEwvuQ}. v703r}e_y/1bDLEHP@lv%kwd⌽Svy۝3g26Ȩ}J*4N8.pnW$T V4 d}\KcSsϹh6A ;.Brp(5`p/m%m_YԔʋO>)-$,$p(? o{:6 ]?Հ{Jjr-|ۋLDJ\yEw%Aaxl,(4m+2ͷ'p(7"i|طJ+UDbɞ5y9R|"UW]U*  8s=w!B2"o&lRda m11P?яV;6(ô5KMAE]2@c(<1*}FX E4|PͫQBޕ!{wV1  _B0c=JY8bBF3'kNh;tԧ8&!bMlA8BlUwk+-AG{n_%% Bk5M C'53C8p8 ba{8T+?jF^k5P~Ěb;@YveAa @y M+^$eҖIN!nvW%vGz ㏗yhp ~_zȋ-1iq@[ow_pvxstԋ2\7͎UGgSF>2 ^ AX k;駟u{S1Rݍy!W|Kv%^z~y [8L\!I\FԞ HH.?RBD!7 VMZlVJ5c|å[ԈvmKL896(:9G-o|2,-&FpχMS?V*+5hojjYd "Zv ,L`bA|1j!;E8T,g}6#"&ؙA E|wy 6 벿޷wM_fԂtP8yWG{&0k.gTȽ\rTpty/ӠXe+=60 LO:+;3ov-Lhd.AÌ{d@Xcr{1(ESboIPa֬BoWk*v>L.;<̓=}{ЪA"^{E'gDѱn=?wjȖ#YzH8hƷ&6`Bt.BOz` @zWAix4i#/jIPaJ2ql0QV k<ܧg(խt'i!A&$9h8lHCH&$0D0O>$^%XH¤(W\4;np;4 wOif1Җ I_$--KWHEq84zwy@+w2g+bsEUK6K 16̹eBΤ]Ek)z%phif5(*Mvtfܜ:Z^C [6RRVmB#*s穁qw_C۔(Zeo!f=]`l䠴o-e9/KDHLozyi|l喝{omMsŘ3::\p`OQdE[IB<aE;>fdЛ~|_wRZlEs#3&3VTY2S$I%IfaتO @,+_(@V<֭)3.:=}H^ *̬0G?2@Eshz@K GǎKc , -R{ QM {6H >7] `G ߮HipjQܲ|GTiz^Fb!Y}IK/u ӖyFNjEtP481R\oT- rϞ-OC,] :F$٧^`,&Cڋ> '#WR+*M<s]s5ٔ)Szj@}!OD>;=*(jSH8. @ow,08V_}G{ICa&9+F; ZČ݅0~X]y䑎6"Uk2RZX J*TYbDb ]@m}~~n]kVR)h-bNiV?&.|vzmݖQ.NF!J# i{^t-91Hq3۝.f. -E`R“OIL_eنn1cPƪ*r<:+Tv|nG}}N`24BF+̺ W]va.j/VlS"$!;h?{"M/CWh\҆2AazDϠ$1eF]6[fw&m茉:C٥C[}HxhTy]ItӧO^[>{SÓ(=L,8H Db%ŗ^ziOJ7#Duڊ7Lk_h܉U7?m߰;q ;,@BW-Vgre$2EJlM~0セ~ !_Y:eۢI'T 8ʂCAKR $& d](<7`NkBJSm*'b-S i:"z7Z趨%X;s)gINs9ى7lF.˅^q@ n>8p *+좸X,m1%7 RMo9vnd(״$ IYF u{B$a1_tQ}{]- @l(d"jАlPʣ!=v43 My"] 8+PܐM/&'ֶK5j[Mz}}u׭ʤO=`N}MI%t9K3A%zy[pG$V޹ K袸Ej6ly9CrvI)٪OvG]uUYH~Xo{zlymyăV1vr lznhoAXDV!T I ܃jb ݶ߿ j R%gGc]vhd{el x<>r ~.zݾ<+4$>w_gtZ]g3gj`NU3+vp1>ip&dMr.9FMI/Ăt!M;T3`|N+aQ"$t<Ȃ l`_r%Ek ]4r&5]ZjZX˶>0v2{)tIU;Uyu$e+ї yfݪN\ZcnԽ$K,Q8wEs#IX5"o!d; "n>DO *(;28>/!fd9tF^Ԍ`=X=#v1>b 0KJ?SOuI|8SD!믿G?lwT66)[D8^ߑ֍KL-;oq`kQY>C]rd0-QwXա) nؤm.x_܆U܆Y>9{Bb.=/{95Ns瞎n,vǪ">%;͖Sw>Fg_\?p].1ںG&]b8߼ 8sa"EX$CS}clVsfY$4@$OIv3sO8I@("NmJ<*#I8vڨ+i>pNXy`Y$jC/@cHYZ*QBV70̃>SQmJ A!vgmJM@צ|B$/yM#$QH"Vj3#+90n&u&Ĵ1#m,o~/">N]̻bib0? AI?g?s xzҤ,t -)S4,`Jh7|I0ٝeVM/4_İ}w6}ܪF*a;RZkn}L$e]'{2 d'pBӟ,oD30Em 8S>cvjDSzUr_NɦA;B_xᅦvw߽aUulZRnQư&^M$C%D^ !8zwvm., F h 7- "sV+ 7%5|-AaGº[G?4z`?\ D~ԧ ESŊU_Ig\ז[n]|NTFDz~G59n|H .5s@ђݱ [@cmIߘ+ɀ]a-,ީ_jO[mJ%XdA`W+}hpԧ>2.[1ρ ?:"Y4c֩c=2SB@F7Vw_0Vh,HXM;l"䔨 n|8ٖV L:#Y@}xVT27)? 2՘hAb$],!b6 'J1M&)SkME܀˷<NobS B$@b-9u Aq =!P !m^$c pj] oZ < y99K~gXC6^+HDYơ q<rnm'k(bM2Pm UCU)ժ0JYZr>㪈1ꄶ-*g }- IH; = ttD[K,D -A/rpeE~I [ ֠`]Sz0Ȃk\MaW4Pa:ĶtaH6RU/bB48DvqNw!tANfL' ,.6թ <2)~76 *CYoC ʽxb gO3קHjl$Й ]Rz,D1ڒi0>M!R픾k#{a< @f@!b\.WЃlR]tQw<>V=sI30#4Ȝ%C! /5eZ3g'=Ў||@~ ET_5 Kb*1j/Amݺ(qc;6j؋'ڞ*9gְFARǎ;8w.mjHbiCыU@'7=}8HPa=`* *Ew}i&_ީs0lD_(y]лbUp@]&daDv~9T%׋ә3%u}D[%"ڗ u7VXaW\_7?tFjQ d _R^qm ]mpM!}FrBRo4X5lVa>$M 08HFĭ7ѧ~nAMǑkst=< š'|ffAâ'CSZ֖i;^>Z1i`3 .%<ShMaV^`>%%A} Ӓ3@P[vgOD#ϝUDJb`$1 qja:YM@CQ{w^[jߏ˛@2"$"3&b}'FM]l|Dj-Z봕*"d%DU3fxf"K|,T l Z&D,.mE!SV CY}Bcb|.Ⱥ50`tԵ'B]U3INBHzǑ&8zJ8M\BҌ ia곱aTh`-<* EdCêHat1WkcDD+ԛF`o>WG0"%*L~?0/C9$n\ ,,ψhTu٤MUEx=^yꌭ&QB{I-R'IM~wA#$z- Mh}==ORld!R6reni*8 p~gNL^m4j]#bK$q ])r_׾Q~'wH1ټ>Rl~ ˆzbP9 Ը%6(oA[]Cʭ{ ;^#Vm ͬDV$ byaҧc+8h#1J]EE sOwa ",mL 6.G/ AZ{ rNDC7Aw|-kMɩ> >P}K) \Dž{ڀ?<ljZE˻ 3E x=Q!b?pcWDo}[fW#Vz`'&C:g}SMYP. 71,clC Z@# ![`0Ke_?5@ -Ov- S>};8ߊ1_ue1q/xհˤ /tATZwd@ns 1ƦkU4vMNJr PwK䝈t=̑v3@ -800ɥ"l, {Rg1!5lu</_HB,h]ea7jhG# ~5xי&vC c !tE7lM@^[qHns1d˺^ήdul~uH^CvעNnذH&dGsgEqX8Te UNQ0VN 2^m:Gʱ B$,pYhwO/LuI݌P;G jmH^G h ' Et>K[C34^d/w㣏|Djir f^ XoHkCbC􉒲pxiʍty70VuQnIy#pRlC%=2d,e+k ćݱNUan]$^Vő3-VX׿Vy~W$%<j#D`p816U j[|*=9p 50Y@,pl%1j/k˓wmL,` ՔenE;# ="qXi0Y{4AXuB;6/+.ah[$9C,`+@~o7+D7>.OktgP9gg`844#0N;TJqJm^"#暥^kH!sʄ> >i gJXAh)`ٖڜal;CRV* J..]f׵_0`el6J $>};%2-Cׂж REŖiۼg\ѬaU"{[ HU_o:OvK[1t_ #[6$9ɍlꮺH+ sᄏ;H%"|Dё#e-4,Rߕ설Wɸ(^b'҆$ļIldס|XKEbrvY0TBwi|~%L&5駟w /ΑHd|s؂p,Ї~+;[1wWn\ 6#7_Dr̷Um%c}%|n馮Ќu[tv'`J[U/"K. ѐ0Qf!h5dUV{p%Xߣv/tHS*P%pȇ10a[`(~@8.QybaV N}] aҸ}vkJZ C)cgUC療L>PwWexF$},3d~Ҷvc һkO$]Uջ)8DZW0EpzzGoӝi SRdck9͉8 6]'؂;d֓ΑT\.bWQnwCƤE]tb@ d<ڵ&61/Xft|QzU^RK{cߋ݁~l934C( 3pW40,Q؀ y)i]]E-oq[EwϤs&9sT&ڳ^Us?+ =3] ;pxڪebܚ]z"Ƕ)`1h9ƤԒE]4`¢>P61Ei|Iq}X076d.nz)Ckwj!Z[zqeFTj2& 1 +p=p DX,`+z, r1]Ki; 1!2FŌ|pIFkp@ߧw-8FèFi=m܋$4v1(wduaB4H;\zKf /'Yh߸:I^!2X)Ozbli9() XO2,C ԖY"$x';3`c-DCܺ=P%#.MTEܟ|#tRϖ2:ɰ7wN;28LA0$rEY2ktaUA9R7"G26$X}DN}c ژ_}ծAE0AUΠuF/JE NŁd)Pkm1^{EF_l J7ي2xߤ3'&'sd1etɣ2^|3KA)aj+Z$c9k ^2]}v.9(v-:tg'A aB|p y(-&YMUW]R!թW[m5XO1YŢ&zJ r B#H*A b>M8gb %f3p)ž9 p >jK,QxD/ BMm27PE$XI(㳝waӿ@Q#%tS`"!D 6[e!=H7x/t ⩮~wa҆I=/80Bi@+5H[S)>b L8wQ_f1`Y=ݷ#7=5e)O?;~H y y! iHX0XcKT`?$[ɓv|]ǂ1p(@iɃtS C1ZC,r2OkpHRK@_fmVd<{gP&2+]݈HW18Ө;Z`sy0XlqZNKH( Xeqn6Ni| ʧ@r7'VbwmhٹDQp߅iFRowEӕax W„3_.:q^ - l^p]$[&|4D Z$9HܲMkIڎ-\r>`0l_[n z P](w|;CۨafLR$Ee '[4E]V+$se0듭[%۲;.6i4dlU; *݇4@a ӣwq3,,HMgqoi d OW18hw`#ִDXPL[]8Ps2v}wot˱v{ʎ5} 8cj)FCqEnb-  mNڕQ+0P@JVj@*7M`:6٤gLHV ⨣ju/b>ODg?`H<HZj)s284Cv n",1V q_hrA>s1 #M?뮻^ԵAMb`ч'p( |jN; ^/nCRe .ޅђܨ#AtVhFa$}.&8hm]W19olz? lcZ[#e=+])<)g4PPLM^Z3I6X`#%OI瓒w>{va $)od[ IJ^D,,s=Q#V+ؕ%1 d7'QLp)@8uS0ɪF `N޴JUcF#7e ]\|O/;*tQ鋅w7F}>}zkOBc$ }yL 1LEAXxN1u.KD8Zkl߯(;$u.b`y/= $p?FDy\7=-$N|ɚ́京L>a%howYf/-C^( )Ce2t@UIɪm=V,zUF Fw* q+4^䀔$9䡨J=apIڸGwUYq&`L>a˛W[mNj|_;I",Io*@" ^oe)[o!1r'h_뽷 䭜0BEHuƃ c[oRH ֦ 'p;Gn@q]HF%Gēq7 g.[x8d뮻nG0sf{oJ HY$[oՅK?J*HLit'8Dj2oOx!t=Np"-Ǐ?8ߜ6>;SSV%thv/O  Fx1'97pÞZ RKuYe8Qh׻CZ:ϻ@J#D:.]G?3ҋCCOC?EVE4.C&x  ;-y[}x_*>&-Nsm&8ԡޘ=+ ubR'^fw^Oz9fLa|pd:hIKrKFԣH ykiӦu,jܞ-4QO} o[:t{Î; t|x;Kߗ47jτ,ڃ>ΰFUz3"I@=5/ #]H0 8{cNLÊ+ zQ̋/3fyG]*|RZpk{ E@3S4С'p(rY/B +tq駟Ik -P6sw q̜93[dE뭷;o6l z!8 9І͹袋fx;\bZ k8>^Fi/+K^}^B@h"9p/E=s9asqw-矟aȹ'ÐOP[;;[vm瀡{Drw"9ַm wߌӞVQ[tH)aB[ʒM= Pޤ=$)Sd+SW~{4'̾8†d}w= $phC2r?.8MG1]~TEHjrA?j{Bw$O;GC#l%mynh5eb>0FQ[!~ѣQ؀/ZzXFc"CtB1o|B_^PyfTE<ӷQg$a̙ٯ~o~"[0O?׿E$ L MD(L[=NEekSO=>Sh@G}47qi]veO~qi~'t/2^#+mڮZ5@k+_zocfvX6gs9g׽.{+^e/^Wgl=n喌BER >ꨣܸp`i/+?ي+ءϾ=~E[oVZ~sϝ]y啅h{|Cl, # lM6,t oȾ- 17v=1"2 f5ycл暞>KGώsyܿnJ3GqD6|KSG>==0-:.Z&`sgg׿~E3(\f/UzUW2g{m ;?ǪMtL^|Fr=Xg o@r| g-0A: /O!~ \-[ve3vx|5811u]ס]u[o\4U8$a<6& HiӦe/˻N>a|;/)D /mg0up`gz$M_{= 2 8$$^i80n#Ѐ|wҋhB1`%p#щ뀃vIZғ15\OOZµw_F\2M6$c1Q<|3y{ϭ]dVr}x{<#9/X`x1ժKGyd!I1<aSv:6vnts:ٵ^ 衇:C Np(sSO="m彗ruPÃgs*hŶnV+"ɳ_}G?q҂/T:Ɲ >I&[vk?;L[Erd~si}|饗v^vaB|;;  AKkVX>h,+FKYK-mOXtEN.R'?6bB_&\oqA^1w{ ڣzӟG36}t]o\ûhWŌ3x$ v\wY}{_/cR+h l guĝUꫯI`HM.j|8Dw< zqtT$ZKsOZV1CbEeKM$VZp  Br,Hyg5a3\,t+q7=F^ds= ;C{wB-xN:$a6V1 c˩Lab-Qw윟{~mQxVL}jZB<)E" vm~H\^  [πD-# |8?8ȥg\=Dk7B뮞Gـ6)w?aq ˤ,v= ֦NڳKvy';n89% HHv It#[h G-86[ܚ"Ĵ {kqM7ukmEҖx+8x.!V}]B?[{ B ]I~q!qp@e$|Оa8,`e`hAz{} -Xy/:;qHCK=ي 0>`猈DyZܧB`|d6wqI_g"y1k 7 w%`nx_~Eryx$8 hEAD?{;+6XY9/^r U2]DIg$k{EX彄 o Y`9*ج 3b ^H O|[R|pqgIHc%`a~衇rФw}]ks}v6ޗ$2\^,E<qFu<~!}F >}hJ~.d<܏ " ~|] n'#I9 CY50.9c97DXxqߪ Hpv ."F|2;4DӼ(ms/nQFRrEB>' 8ڌ&  DDQ@QD>Q C^(0jH0j3(' $pkF FmRD}"tzMQ èXo@(ONI5 $pKM85FY8X ;D!\'8لɒD)3iSu='YͩʺytN&|>j6ikURvrD<Ǹ8*\v~~ȉ@9 ZFdӢ](c|?Nѱ<<#ߓZ 6vq|Çr;iK= JVqj[jRJ'HH2NsjܡpvH*V\qp)Hyxe2ǮIE 2t -K<0TE! >Oo~ِtf 9ٌXPg2*׫Z9InHG#K#r7|p]/|'Eqbn%Q,)_?< `uJsf| 76@>`IMC/V1E#'ZwB*m@} SNAd+MM,W0\$/85o'-u] CFCxV]uUo]X[^1`'^ ͈!гv?ZCOUAo,<$]Ůc $s%`IA>siH)}|F@@8 ECv6%aDgҒ|jcǐ =^g^XD8hZ!0G ]vJmX%v|;$@y/|.O?J`$񢑜`ѥY_u'WevTCuw)l-_j ;@QYÍ#;GM21H|RK"LjĮOIwAa VRT6BiӦ䱸fʂx'l.û`6MI|J8]ש_B^gu w8X`%AJ>i{PG4_H0܏!?|5Vuip8dq|ح,mߨ|v;; 'm^,(1 Q(lg| K, yj.v7[lCŐ `0VqgZTޤA/t\@7>{Z!tp^yf ږ i)Ge%LuK,8`!&3& BIgs:'"gh}SNZk 1HC(",m!L] RCv_s^T$wp?b4wO?t"p;#Bcam U lZ;qϠ3u&ʨ{-tƥ]>rSUrBHyC;ՖS  Y8>Iiyp@1uD$bv 2AXNzN2fΜ邳B2?8`ʓ0j~ $ꥯl7pIZ^ Jڧ!_4 >%-MAV>XIJ .MPMZH )ϢPެHFbIte7 AK,b%B%ź"`/!}. =y4bh 8V:?8Bs΢`p-#.wghCAevumƱGOYpu$T->`3gSIp"t^0D$5oqIK.dCz*])@Vo|r tאx=w[aW+Qc@ +$ {ooE"p15x1z~qj==$"79Swi旈Ue=o =@3I? ئ8&gTk8"!묁*xjkcz+9&9dT`QMP|79 ,/F#,q3OdE9ycʨyc(27SwA .EgX$ƌä3O $sGUA5nvBuej5BDEwĭ1qt (  ;VXa\p`jUBsy`"<B27lS#laΑx|[ċVo_6ό V;c "⏝CA ZYH >FnEGk{=ŨL2&QQ6zB\>p",@ߊVz#SuOejp&l=o%gHГtQ eG+H058U󤇪iA]x(i :ɣ?6*X}?]ٗ1OS.Kahoڿ+s`,LL!?>'9 s~95ua_(o,MH@<,7xX/Iț{s,+ZIpG cP oGҮ8hۊj434ly1%z3+9ȩٖUWrj]s>;x+ fN0w*3Z\>N %D, t,0k%.?vYs ދUG (X$0D#҃9m[A\Ĵh0žVJ9`gwQ/,Aڇ$ᩣ>:TsLCy~X:䆶A.jzp_8`["pa$;kȧ>ZoF̍m R|jE$'#I|FJzc,S=I:8H&6HHqb܊W,'7>&һl6*dR}&2΋`)@gcb:@ݷ: o#Od I Ρ 9W(Y8iC$q~XRxKxYlNHy:6乫V S2i_!u'^EAŁصY z+R+c{Z\N!set>c;`DcI|zXk%˴@RMgaz6pMxo+{\ D\Ry@Y g[AC(̍CȮLlHH:: s9pEX*Z"r>Vl1.w_¬L ^"a6 }vV6Q"2˳U .Gm̳9zl4d$vBjE1j,JWd^9h IERO% YuA aDؘK HXcc\Cu$-~"b`m*L~b{>ĤTdQ"׼0ˡ"=N;BRD_jzr%eӒVdy2x(_;ٟ&D35R7FG\E cYx$3&8tƘ8KA|*$R_Cp2fe>z SjYOZ0Y1"UH\ىА !6?JV W47ħH]w.)./UfwH͢~0Xq궵_S@sƣ^Iβ4i8!2D/d Et#I9л0RDbÿ́tRbPUT=KxxӪAW`w ՝Sr.\vB~=X]~3៶8t#T4yIXTL6KҮ+mH _O HQhH3f̈#D6l,]~.xFT3H|XZ̏O< R7_N; @9 D!N5%%z>R-ͅ{N)[R񐕀Ax>TDLg+xpJ΋%4+ }!~M{c-~^Bv"ĴkU?|;wXCWԗ:GӼJ>V`^ϖom+pMp쀫g."y2~w| njE;XeǗ䡅'gtO,4996|ڷx-o d |d+Cۻe"\S;O#2R}E:vLUvf d8c1eb@:$5փ&1mh-h.bx!9?Q Q`|)a|6,Q8"_z8Q`|)a|6,Q8"_z8Q`|)a|6,Q8"_z8Q`|)a|6,Q&bTB$1֚ F$5ݏm+ౢ 6* 7/n( ~ :}4ȋeʘw=>'&/W1mH^b*替лb)8X"[ؖк-h`*z2-_@*`k:B-|]QNo1[>IiɁy+y+)HESPY*@Jm,7aCf$|4X6u13!}$IT6X< 33.m.Ey^tD8"̓K+QgwՓ`D_{j9묳f0}R_!P?Gv.;X6#`io%- xZNF/_ =**!z= byK%4e#|pXc "Y. (6M,>(8Xf %'< K3]ødE&k&.\c2dIŎ&@l3.HMd"SUNr7|;CWRWSBEod>-vi 8X@91fɲJMV[j)B98gyKd#V 2y)Źtz[1#u/,+94qZM!^$$0f,)YRP$-M*Ʌ(@|Er;/%ذ-bK߯ ܀y"9?pn80>Yi\BGD"=$6=Ӭz %۰w}. gCvY1edCq:5s_}'ʤ#F¸iԩ w}WUɁID- ]ѣM] KK>Cu)&ŐV-İ>iJou JԮxg ԗ^z0nx ~}OBF`hR$9pc#݉!G1CLE\  !tRb$iS*ـCL}WL6ݦ]2$eb7DXɵhOirȪ쫫i[cV P䖣_!QK?#/C[zWgֻb߇*BY;oدR+̨!v/jkdx`PO{lHYLk"eR|^f_W3a.TLfGP.䳝’-pfbt1Zc$Rb3-@v.SfMpwtA=տm7͇{*ZMүU+}0jt+ jy֒`Ӡ}hA{b@ [nq$wp`z.+P4a eub^3Έ\KAY-җyU0pjmwɎ-2D@́pލIӃ0$CdqEq9蝅㬛p٥TKtֻ;0' w<o[r(q128tU<Mؤ $OA3H\mfY:ag6+9 / :lJ*önCؓN:c.d,.&@?/ejp^u!Ɩ["$58KG}{_vZp:69()F';!Vo8{ݞyn[ ĮAy"P#RH;Z>AX{>pڍ jױPg=;0pdʀ ?\n]7pi(J@jSJZ]y!qS/XE[hZUrfc'6RlgR"Ϝ Hmpڪ'#CZj[PbA6lf+$9-: p(sH.c!s% h-wI,;` p\mA^ɳ>BA KC*8{І;kK`=mdA޺u?? 68믿gq#}u]=҃wT( 7 =,+MG}J 1 Bg/胉îbM5\,L|v!U]h_bբj8Hg nAJ@x!ml?:Xi$~:zj 42gv2.4b@eD9 349>D$N%q"%\џi,v2bg;M Z*@4au{>c߉ ƚԊ( ;kwgOp APzC}VxH F>Bcx Zw. b}1jhľU4S$9H_dCUYJއ@ xYpIDЮxϏf-2,܇A3* 'BӮDhPo Fr *H w!ƌJ7@}^c:[v`0Oj/* K4?hmԀ+Uރ4LtOj= J@#eÅXg]/hhˤ9bQ_~x6ˤYt5VAl!ڂվ3am@*ҋ}7l0J> F_q=~t߬5ptc]z1$9Dຒ f}Vov0\d һj̍/2],*e 8`4t43ǪJ;,rH rOq  !UH/}c]R3g.c8 f`7qT[ұI[$J7v+c"$XE\?ǿ9m% 8c0<<v q'jȎ(RW.F0TAGKA{45Y[lEv1dW]uS|f( 10~mp à/bw̵;gu? ~{ҔJud eW@s\Em `,tIENDB`DyK yK Pmailto:ccoman@psoriasis.orgyX;H,]ą'cDyK yK Lhttp://www.psoriasis.org/yX;H,]ą'c$P@P sNormal ^ CJOJQJ_HaJmH sH tH V@2V s Heading 3dd@&[$\$5CJOJQJ\aJDA@D Default Paragraph FontRiR  Table Normal4 l4a (k@(No List NON Heading 3 Char5CJOJQJ\^JaJJ^@J s Normal (Web)dd[$\$OJQJ:U@: s Hyperlink>*B*^JphH@"H s Balloon TextCJOJQJ^JaJBO1B Balloon Text CharCJ^JZY@BZ s Document Map-D M CJOJQJ^JaJBOQB Document Map CharCJ^J.W@a. sStrong 5\^J4@r4 sHeader  !BOB  Header CharCJOJQJ^JaJ4 @4 sFooter  !BOB s Footer CharCJOJQJ^JaJJV@J sFollowedHyperlink>*B* ^JphVOV sList Paragraphdm$CJOJQJaJd0@d s List Bullet# & F hd^h`CJOJQJaJF'@F sComment Reference CJ^JaJ<@<  s Comment TextCJaJFOF sComment Text Char OJQJ^J@j@@ "sComment Subject!5\FO!F !sComment Subject Char5\2X@12 ,63Emphasis 6]^J,^rFG./x, L B C J O P "# !   @0@0@0@0@0@0@0@0@0@0@0@0@0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0 @0@0@ 0 @ 0 @0@0@0@0@0@0@0@0@0@0@0@0(@0@00000000000000< i CBrXXl,b$ o,AB/T+߂t"<,@|(    A ?2. "C:\..\Documents and Settings\sdebusk\Documents and Settings\sheila\Documents and Settings\sdebusk\Documents and Settings\sdebusk\Local Settings\Temporary Internet Files\docs\Shared\LOGOS\Black & White\without tagline\PsoriasisLogo_Vertical_bw.gifPicture 2../../../../Documents%20and%20Settings/sdebusk/Documents%20and%20Settings/sheila/Documents%20and%20Settings/sdebusk/Documents%20and%20Settings/sdebusk/Local%20Settings/Temporary%20Internet%20Files/docs/Shared/LOGOS/Black%20&%20White/without%20tagline/PsoriasisLogo_Vertical_bw.gifDDS`TS`TD"B S  ?TL @    JɸC<.,"l H( 'pP>S @Mu E3} ;:l (Pd%?"UTs.6d,juj"w"6$s\30L<85V @8N`pGRW~#M~Z8k`NwgkAU-?V4 J3_{0af;2"!|kzuo~!U.tI$(u80 hh^h`OJQJo(^`CJOJQJo(^`CJOJQJo(opp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo( ^`OJQJo( p^p`OJQJo(o @ ^@ `OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( P^P`OJQJo(o  ^ `OJQJo( ^`OJQJo( ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo(^`B*OJQJo(ph ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo( hh^h`OJQJo( 88^8`OJQJo(o ^`OJQJo(   ^ `OJQJo(   ^ `OJQJo(o xx^x`OJQJo( HH^H`OJQJo( ^`OJQJo(o ^`OJQJo(^`CJOJQJo(^`CJOJQJo(opp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo( ^`OJQJo( p^p`OJQJo(o @ ^@ `OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( P^P`OJQJo(o  ^ `OJQJo( hh^h`OJQJo( ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo(^`B*OJQJo(ph ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo( ^`OJQJo( p^p`OJQJo(o @ ^@ `OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( P^P`OJQJo(o  ^ `OJQJo( ^`OJQJo( ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo(^`CJOJQJo(^`CJOJQJo(opp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo( hh^h`OJQJo( 88^8`OJQJo(o ^`OJQJo(   ^ `OJQJo(   ^ `OJQJo(o xx^x`OJQJo( HH^H`OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( p^p`OJQJo(o @ ^@ `OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( P^P`OJQJo(o  ^ `OJQJo(^`OJPJQJo( ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo(^`B*OJQJo(ph ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo( 88^8`OJQJo( ^`OJQJo(o   ^ `OJQJo(   ^ `OJQJo( xx^x`OJQJo(o HH^H`OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo( 8^8`OJQJo( ^`OJQJo(o  ^ `OJQJo(  ^ `OJQJo( x^x`OJQJo(o H^H`OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo(^`CJOJQJo(^`CJOJQJo(opp^p`CJOJQJo(@ @ ^@ `CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(PP^P`CJOJQJo( 88^8`OJQJo( ^`OJQJo(o   ^ `OJQJo(   ^ `OJQJo( xx^x`OJQJo(o HH^H`OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(opp^p`^J.@ @ ^@ `^J.^`^J.^`^J.^`^J.^`^J.PP^P`^J.^`B*OJQJo(ph ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo(`h^``56B*CJOJQJo(ph ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo(88^8`CJOJQJo(^`CJOJQJo(o  ^ `CJOJQJo(  ^ `CJOJQJo(xx^x`CJOJQJo(HH^H`CJOJQJo(^`CJOJQJo(^`CJOJQJo(^`CJOJQJo(8^8`OJPJQJo( ^`OJQJo(o  ^ `OJQJo(  ^ `OJQJo( x^x`OJQJo(o H^H`OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo( hh^h`OJQJo( 8^8`OJQJo(o ^`OJQJo(  ^ `OJQJo(  ^ `OJQJo(o x^x`OJQJo( H^H`OJQJo( ^`OJQJo(o ^`OJQJo(^`B*OJQJo(ph pp^p`OJQJo(o @ @ ^@ `OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( PP^P`OJQJo(o   ^ `OJQJo(%?"85?V ( ,N`pG:l .6~#MgkAUMu "af!U.ts\3l >S J3_Ts@8k`NE3} (uC<uj"!|kzuo                                            >?                                                                     ݊1                                           @}26                                   MtBR&C&-sWT| ', 1U . O ]*Ij1^#s9 !6|!0 "%'=')+1+N<-q-T$.\/C3,634 4b5I}7,&<U<]<%/=P=F>;?H@ABCVzCD#CDUEc.EpE+HjH JF(KzLxgN>O>^QtWfX"Y%Qc #J[@."9UY+S]_'> ZSKMpgAi@@Unknown Gz Times New Roman5Symbol3& z Arial9Garamond7K@Cambria5& zaTahoma7&{ @Calibri?5 : Courier New;Wingdings#hTFTFY 4 "4 "!94d2HX ?b52FOR IMMEDIATE RELEASENonenbaker|                       Oh+'0 $ D P \ ht|FOR IMMEDIATE RELEASENone Normal.dotnbaker2Microsoft Office Word@@= @@@@4՜.+,D՜.+,D hp  None" ' FOR IMMEDIATE RELEASE Title P(` _PID_HLINKS_AdHocReviewCycleID_NewReviewCycle_EmailSubject _AuthorEmail_AuthorEmailDisplayName_ReviewingToolsShownOnceAUhttp://www.psoriasis.org/3mailto:ccoman@psoriasis.org VC:\..\Documents and Settings\sdebusk\Documents and Settings\sheila\Documents and Settings\sdebusk\Documents and Settings\sdebusk\Local Settings\Temporary Internet Files\docs\Shared\LOGOS\Black & White\without tagline\PsoriasisLogo_Vertical_bw.gif0Press release on Dr. Tuttle psoriasis grant NBaker@psoriasis.org Noe Baker  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVXYZ[\]^`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F0C Data W1Table_hWordDocument^SummaryInformation(DocumentSummaryInformation8CompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q